Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety alerts Dexamethasone 4mg/mL injection changes Dexamethasone injection 4mg/mL (Organon) has been acquired by Aspen pharmaceuticals. They have reformulated the product and it now contains 3.8mg/mL dexamethasone, available as a 1mL vial, which requires storage in a […]
Category: Updates from www.palliativedrugs.com
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics Electronic prescribing for controlled drugs – DH consultation The UK Department of Health (DH) has published a consultation document on proposals for electronically prescribing Schedules 2 and 3 CDs in both the NHS and privately. […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics Ketamine rescheduling consultation Ketamine was classified as a Class B drug, under the Misuse of Drugs Act, on 10 June 2014 in the UK (see our news item 6 June 2014). The promised consultation document, […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates Class 2 Medicines Recall: Midazolam buccal liquid 10mg/mL (unauthorized) The UK MHRA has issued a class 2 medicines recall (action within 48h) for specific batches of Midazolam buccal liquid 10mg/mL, 5mL (unauthorized product manufactured under […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates Reminder of risk of life-threatening harm from accidental exposure to fentanyl patches The MHRA have sent out a reminder of the potential risk of life-threatening harm from accidental exposure to transdermal fentanyl patches. Cases of […]
News and updates from www.palliativedrugs.com
9th June 2014 Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics NICE Evidence Update: Opioids in palliative care The UK National Institute for Health and Care Excellence has produced a summary of the selected new evidence relevant to the use of opioids in […]
News and updates from www.palliativedrugs.com
2nd May 2014 Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates EMA restricts domperidone dose and duration of use The European Medicines Agency (EMA) has recommended changes to the indications, dose and duration of use of domperidone in adults and children following a […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics Tramadol to be a Schedule 3 CD and temazepam exemptions to be removed The UK government has decided that tramadol will become a Schedule 3 controlled drug (CD) later this year, but will have exemption from […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Latest additions PCF updated monographs The online Palliative Care Formulary (PCF) is being continually updated. The following monographs have been updated during February 2014 and supersede those in the publication of the 4the dition of the Palliative Care […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates ACMD recommends reclassifying ketamine The UK Advisory Council on the Misuse of Drugs (ACMD) has recommended that ketamine be controlled under the Misuse of Drugs Act 1971 as a Class B substance (currently Class C) […]